Mobia Medical, Inc. MOBI
12.26 USD +1.07 (+9.56%)
At closeNov 9, 2026, 4:00 PM EST
12.11 -0.15 -1.22%
After hours · Nov 9, 4:00 PM ET
9.94 Day range 12.31
8.03 52-week range 15.29
- YTD
- +4.34%
- 1 year
- +4.34%
- Market cap
- 408.15M
- EPS (ttm)
- -2.96
- YTD return
- +4.34%
- 1-year return
- +4.34%
- Volume
- 178.28K
- Avg volume
- 208.61K
- Open
- 11.22
- Previous close
- 11.19
- Day's range
- 9.94 – 12.31
- 52-week range
- 8.03 – 15.29
5D +0.34 (+3.13%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Financials — quick view
MOBI Revenue — quarterly 15.62M
MOBI Net income — quarterly -17.34M
MOBI EPS — quarterly -0.52
News
What Mobia Medical (MOBI) Said on Its Q3 Earnings Call 
Sky-mobi Q3 2026 Earnings Call Transcript 
Mobia Medical Raises FY2026 Sales Guidance from $54.000M-$56.000M to $57.000M-$57.500M vs $55.030M Est 
Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference 
Gap Posts Upbeat Q2 Earnings, Joins Solstice Advanced Materials, N-Able And Other Big Stocks Moving Higher On Friday 
JP Morgan Maintains Overweight on Mobia Medical, Raises Price Target to $17 - Mobia Medical Sees FY2026 Sales $54.000M-$56.000M vs $53.504M Est
Mobia Medical Q2 EPS $(1.10) Misses $(0.82) Estimate, Sales $13.505M Beat $12.380M Estimate 
Mobia Medical Announces Publication Of 2-Yr Follow-Up Data From VNS-REHAB Study In Neurology, Official Peer-Reviewed Journal Of American Academy Of Neurology - Mobia Medical Says CMS Proposes To Maintain Vivistim CPT Code 64568 Under New Technology APC 1580 With ~$45,000 Outpatient Payment Rate For 2027
Your note
Sign in to keep a note on MOBI — it syncs with the Stock Master app.